Schranz Jennifer
Insider CIK 1735382 · NBRV Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-02-28 | 2021-03-02 | 33 | $2.39 | $79 | 39,125 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2021-01-31 | 2021-02-02 | 36 | $2.62 | $94 | 39,158 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award | 2021-01-29 | 2021-02-02 | 22,500 | — | $0 | 39,194 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-12-31 | 2021-01-05 | 30 | $2.42 | $73 | 16,694 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-11-30 | 2020-12-01 | 301 | $0.43 | $129 | 167,240 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-10-31 | 2020-11-02 | 301 | $0.50 | $151 | 167,541 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-09-30 | 2020-10-01 | 301 | $0.53 | $160 | 167,842 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-08-31 | 2020-09-02 | 301 | $0.62 | $187 | 168,143 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-07-31 | 2020-08-04 | 301 | $0.76 | $229 | 168,444 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-06-30 | 2020-07-02 | 301 | $0.67 | $202 | 168,745 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-05-31 | 2020-06-03 | 301 | $1.14 | $343 | 169,046 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-04-30 | 2020-05-04 | 301 | $0.55 | $166 | 169,347 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-03-31 | 2020-04-02 | 301 | $0.58 | $175 | 169,648 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-02-28 | 2020-03-03 | 301 | $1.35 | $406 | 169,949 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2020-02-06 | 2020-02-10 | 210,000 | — | $0 | 210,000 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award | 2020-02-06 | 2020-02-10 | 105,000 | — | $0 | 158,705 | SEC↗ |
| NBRV Nabriva Therapeutics plc | F Tax w/h | 2020-01-31 | 2020-02-04 | 4,295 | $1.35 | $5.8K | 53,705 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2019-01-31 | 2019-02-04 | 52,500 | — | $0 | 52,500 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2019-01-31 | 2019-02-04 | 235,000 | — | $0 | 235,000 | SEC↗ |
| NBRV Nabriva Therapeutics plc | P Buy | 2018-06-22 | 2018-06-25 | 5,500 | $3.73 | $20.5K | 5,500 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2018-03-30 | 2018-04-03 | 150,000 | — | $0 | 150,000 | SEC↗ |